chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt sick like mild flu symptoms following day (not concerned about this). Felt GREAT 2 days after (better than usual even) but by 3 days after injection (Tues, Sept 13, 2022) suddenly had some trouble breathing and walking. Balance seemed off. Not dizzy but it took more concentration to walk. Loss of coordination. Trouble walking/standing especially in a dark room or with eyes closed. Looking at a monitor while scrolling caused dizziness. Constipated. Weak and sleepy. Considered ER treatment but decided to take a shower and sleep. After sleeping a couple hours, decided that trying to walk would help. Successfully walked around the block but returned feeling very tired and dizzy.  Went to bed EARLY (8pm). Woke up Wednesday (Sept 14, 4 days after injection) still not feeling "normal" but breathing ok. Still some loss of coordination.  Extremely constipated and just feel odd. Took 2 docusate sodium and half  Xyzal (2.5mg) orally. Not very productive day. Weak. Not getting worse on Thursday (5 days after inj.). Stopped taking the Xyzal. Continued the stool softener. Friday (6 days after) working more or less normal but still a little off. A little more focus to breathe but not getting worse.
COVID 19 Treatment/caught Covid January 8, 2022 after starting the vaccination process; COVID 19 Treatment/caught Covid January 8, 2022 after starting the vaccination process; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received bnt162b2 (BNT162B2), on 16Mar2021 at 11:00 as dose 1, single (Lot number: EN6208), in right arm and on 06Apr2021 at 12:15 as dose 2, single (Lot number: ER8734) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known Allergies: Pneumococcal 20-Val Conj Vaccine, Vancomycin, Cortisone Base And Pcn Penicillins" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 08Jan2022, outcome "unknown" and all described as "COVID 19 Treatment/caught Covid January 8, 2022 after starting the vaccination process". Therapeutic measures were taken as a result of vaccination failure, covid-19 with Paxlovid from 07Oct2023 to 12Oct2023. Clinical course: Patient also received bnt162b2 (BNT162B2), on 22Feb2022 at 03:15 as dose 3 (booster), single (Lot number: FM0698), in right arm for covid-19 immunisation.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300334047 Same patient, different product, different dose/event;
history of woman having problems with her menstrual cycle; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (history of woman having problems with her menstrual cycle) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER (history of woman having problems with her menstrual cycle). At the time of the report, MENSTRUAL DISORDER (history of woman having problems with her menstrual cycle) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
After 1st shot: sore arm (24hrs) - limited movement in arm when in certain positions above head (still continuing) 2nd shot: sore arm, limited movement in arm when in certain positions overhead chills, body aches, fatigue, sore arm, swollen node underarm (lasted 36hr after shot) 2 weeks after 2nd: still limited mobility in arm in certain position (not to the touch, more the muscle in certain positions)(more of an discomfort rather than sharp pain)
Case number PHEH2013US024861, is an initial spontaneous report received from a medical assistant on 25 NOV 2013. This case refers to a male patient of unknown age. He was vaccinated with FLUVIRIN 2013/2014 (batch number: 1308401) intramuscularly on 25 NOV 2013 which was not stored under the recommended temperatures. Reporter stated that, their power went out sometime over the weekend and may have reached room temperature. Duration of excursion was not known. When the power came back on, the refrigerator malfunctioned and some of the liquid in the fridge froze and it was not known if FLUVIRIN froze. No adverse event was reported following this administration error.
Patient to ER 11/1/23 with chest pain and diagnosed with Acute PE.
dizzy spells; stiffness in face; tightness in face; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy spells), MUSCULOSKELETAL STIFFNESS (stiffness in face) and MUSCLE TIGHTNESS (tightness in face) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced DIZZINESS (dizzy spells), MUSCULOSKELETAL STIFFNESS (stiffness in face) and MUSCLE TIGHTNESS (tightness in face). At the time of the report, DIZZINESS (dizzy spells), MUSCULOSKELETAL STIFFNESS (stiffness in face) and MUSCLE TIGHTNESS (tightness in face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that patient does not use insulin for diabetes. He just does exercise and takes a blood thinner.  Patient has tried to correct the events with exercise.  No concomitant medications were reported.
Within one minute of receiving vaccine (FLUZONE) states became sweaty, had chest pain, heart was racing, felt like she was going to pass out. Had pain radiating down arm of injection site, left arm. States symptoms were much better after a few minutes and by 10:50 "felt almost normal" - Has had flu shot in the previous years with no problems/reactions.
I contracted COVID. It started with a cough, then muscle aches, have a hard time talking, and severe congestion. No fever. The coughing is started to fade a bit within the last 2 days but I am getting worse with aches. No medication is being taken for it.
Narrative:  36 year old male patient reported muscle pain for two days following his second COVID-19 Pfizer vaccine on 02/19/2021. Patient had his first COVID-19 vaccine with no reported problems.
Pain in arm, body aches, moderate headache, chills lasting 5 hours, fatigue with shortness of breath from light activity, mild dizziness, and generally feeling ill. Lasted approx. 24hrs. Body aches and mild fatigue the following day.
Sensitive eyes, sudden and intense head cold symptoms all at once.  No medications taken much Vicks used. Slept most of next day symptoms gone by next evening but still tired until 11/01/2015.
I have had no congestion, itchy eyes, shortness of breath while exercising or a running nose. Nothing has changed other than the vaccinations.; This is a spontaneous report from a contactable consumer. This 66-year-old male consumer (patient) reported that he received first and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown, and Expiration date: Unknown), via an unspecified route of administration on unspecified dates in 2021 as 1st dose, single and 2nd dose, single for COVID-19 immunization. The patient medical history included ongoing allergies, hay fever; and congestion and stuffy nose during pollen season (since childhood). The concomitant medications for patient were not reported. The patient reported that he had history of allergies, hay fever, congestion and stuffy nose during pollen season since childhood. He completed the two doses of Pfizer COVID vaccination along with his wife in 2021. This spring, despite of very heavy pollen, the patient had no congestion, itchy eyes, shortness of breath while exercising or a running nose. Nothing had changed other than the vaccinations. The patient wanted to make aware of this in the event this was a possible positive vaccination side effect. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Left deltoid became swollen, client states (was heavy) mild rash on arm, face left side. Rash barely visible when presented @ the Grady Co Health Dept 2:00pm 11/16/04
sore arm, fever, heart felt like it was fluttering for 2 weeks, tired, foggy brain
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Nov2021 at 12:00 as dose 3 (booster), single (Lot number: FF2593) at the age of 49 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ADVIL COLD & SINUS, start date: 11Jun2022, stop date: 11Jun2022 and also reported as patient took other medication in 2weeks. Past drug history included: Phenagren, reaction(s): "Known alllergies: Phenagren". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 13Jun2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Results; (13Jun2022) Positive, notes: I tested positive Monday 13Jun. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid started on 12Jun2022 and stopped on 16Jun2022. Clinical course was reported as, patient tested positive Monday 13Jun. Got the antiviral medicine that night. 5 day treatment. Patient was feeling much better she would say she started feeling bad again on that following Tuesday 21Jun. Headache not as bad but allergy and flu type symptoms. 100.1 fever on 20Jun2022 at 15.00. No treatment received for symptoms and patient was not recovered from symptoms.  No follow-up attempts are possible. No further information is expected.
Expired Fluzone Quad was given to a 4 year old child in error with no adverse event; Initial information received on 21-Nov-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).    This case involves an expired Fluzone Quad was given to a 4 year old child in error with no adverse event (PT: Expired product administered) for vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (Lot UJ009AA, expiry date 30-Jun-2019) via intramuscular route in the right arm on 21-Nov-2019.   Medical history and concomitant medication was not reported.  It was a case of actual medication error due to expired vaccine used.  It was unknown if any adverse event occurred.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Shortly after receiving MMR and Prevnar vaccine patient began to regress, blank stare, lost language, lost socialization skills, ear infections, eczema, allergies diagnosed. Patient had none of these health issues before this time. He lost all of his skills and went from being healthy to sick constantly.
1/15/2022 He was also diagnosed with COVID-19 infection during his hospital stay, though did not develop any severe symptoms prior to discharge. CT imaging was obtained and he was found to have acute appendicitis.
Fever 104, NV within 24 hrs of vaccine. Local reaction 8cm. Tenderness, induration, & warmth at injection site.
Delayed reaction: Swelling, redness and itching at injection site 8 days after vaccine given.  In progress
Swollen left arm, extending from shoulder to elbow, redness, hot and painful for 4 days. Used ice packs and resolved within 4 days.
Contracted Covid 5/19/22.  Took Paxlovid.  MIld symptoms (cough, sneezing, runny nose, head- and bodyaches) all lasted less than half a day.   Vaccine #1 (Moderna, 3/28/21) - no side effects Vaccine #2 (Moderna, 4/25/21)  - itchy chest rash,  Duration unknown Booster #1  (Moderna, 11/18/21) - itchy chest rash 11/20 - 24/21.  And again   12/14 -18/21   Booster #2 (Moderna, 4/26/22) - itch chest rash 5/4 - 5/17/22.  Itchy back rash 5/13 - 17/22
sick to stomach; cold, high blood pressure-fast heartbeat hot tingling in hands, arms, back & neck-weakness, no appetite, lost 8 lbs, loose stools, sometimes sweat, unsteady movements-extremely nervous
6 days p/vax pt died suddenly @ home;father was holding pt & fell asleep when awoke pt not breathing- had be fussier than usual;Autopsy report: interstitual pneumonia, mesenteric lymphadenopathy, passive congestion of viscera;COD pneumonia
had two seizures after second covid vaccine (a minute each, about 15 minutes between seizures)            stares, jerking, choking noise, got stiff            occurred 25 minutes after vaccine            different from usual seizures in that when came to didn't know who he was, his name            had fever to 101.1 (rectal)            given tylenol            no rashes            +headache after seizure            poor appetite that day but drank well            was back to normal next day
11/05 - Influenza, live, intranasal vaccine (vaccine record date reflects 8 Nov 05) was administered while performing (weekend duty); 2-3 weeks later (week after Thanksgiving) developed sore throat; slight fever, stuffy head & other flu-like symptoms; 12/05- Sore throat continued, noticeable rash appeared on thighs & small lymph nodes on face; 1/06 - same symptoms continued intermittently, visited ENT @  Med Ctr for sore throat, ear pain & advised possible allergy; experienced joint pain in fingers, wrist, slight swelling in right knee & ankle; 02/06 - Emergency Rm vist to Med Ctr for burning rash on body; Mar 06 -Visit to Family Clinic for rash on body; Mid 4/06 - sore throat continued with high fever, body pain & swelling of fingers, wrists, knees, ankles & feet; Hospitalized: 4/17/06 @ Med Ctr; Diagnosis - Undetermined, Discharged 5/9/06; Hospitalized: 5/10/06 - Hospital, 2; Diagnosis 5/25/06: Adult Onset Still Diease (intially 60 mg of Prednisone, reduced to 3 mg; at present, regular visits have continued w/ treating physician since hospital discharge date - Dr. 11/9/07-records received from patient for hospital stay DOS 5/10-5/26/06-DC DX: Still disease. Temp 102.2, Bilateral axillary lymphadenopathy. Leukocytosis. Generalized body pains, weakness and extensive mascular rash especially on tongue and chest.
Patient had shingles which took a year to resolve and was fully better December of 2020 before she had the first inoculation of Covid.  On 1/20/21 had the Pfizer jab and on 2/9/21 the shingles rash had returned in the same area as before.  Redness, edema, and complaint of itchy patch.
Pt developed rash all over 7/1/01 - but worse on face, irritable, appetite decreased, fever of 101F - axcillary started 6/29/2001, Rash fading 07/03/01.
Patient tested positive for COVID while traveling. Symptom onset 7/14. Completed 10 day quarantine. She is fully vaccinated.
Pain at injection site; Severe headache; Myalgias; Fever; Chills; Night sweats; Weakness; This is a spontaneous report from a contactable physician (patient). A 32-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK4176), via an unspecified route of administration in right arm, on 13Jan2021 at 10:15, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (Lot Number: EK9241) on 24Dec2020 at 12:15 PM for COVID-19 immunization (left arm) and developed pain at injection. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The facility where the vaccine was administered was in a hospital. On 13Jan2021 at 8 PM after the second dose, the patient developed pain at injection site similar to the first dose but also developed severe headache, myalgias, fever, chills, night sweats, and weakness about 8-10 hours after the injection that lasted throughout the night. The patient was currently more than (>) 24 hours after the second injection and while most symptoms have resolved, the patient still had significant weakness and myalgias. Treatment was received for the events including paracetamol (TYLENOL). Post-vaccination, the patient has not been tested for COVID-19. The patient was recovering from "Myalgias" and "Weakness". The patient recovered from the remaining events in Jan2021.
Major Stroke, AFIB, clot in right side of brain, left side of body paralyzed.  Clot removed mechanically.  10 days in hospital.  3 weeks at Rehabilitation.  Ongoing PT and OT.
After receiving vaccine my monthly cycle was thrown off by one week.  This happened after both shots. First and second. Now right before my menstrual cycle I have started getting shooting pains in my breasts. This continues for the entire time as well as a week after. It comes on randomly.
This spontaneous report as received from a pharmacist refers to an approximately 72 year old female patient with allergy to sulfa drugs. The patient had no pertinent medical history. On 08-OCT-2015, the patient was vaccinated with a dose of ZOSTAVAX injection (lot# reported as L012039, expiry date 07-JUL-2016; dose and route of administration were not reported). There were no concomitant therapies. In approximately October 2015, reported as "soon after" the vaccination, the patient developed a bruise at the injection site. The patient sought medical attention-she came into the pharmacy to show the bruise to the pharmacist and reported that she did not experience any pain or other symptoms since receiving the ZOSTAVAX. No treatment was given for the event and no diagnostic lab studies were performed. The outcome of the event was reported as recovering. The relatedness between ZOSTAVAX and the event was not provided. Additional information has been requested.
fever 99.3; 3rd day felt 80% better; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In September 2021, the patient received the 1st dose of Shingles vaccine. In September 2021, less than a week after receiving Shingles vaccine, the patient experienced fever and feeling unwell. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever and feeling unwell were recovering/resolving.   It was unknown if the reporter considered the fever and feeling unwell to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient got the shingles vaccine and got fever 99.3 degree F, 3rd day patient felt 80 percent better. The patient took Tylenol for 2 days. The patient mentioned that better than the break out what he/she heard. The follow-up would not possible as information was not available.
(L) upper arm vacc site. Asthma exac w/ST, cough, 3 days later. Per physician.
Fatigue, achiness after vaccine, low-grade fever that evening, took ibuprofen, could not work the next day
Inflammation around the heart; shortness of breath; chest pain; administration date=17Apr2021, Dose 2/administration date=07Apr2021, Dose 1; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 26 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 17Apr2021 (Lot number: EP6955) at the age of 26 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot Number: ER8743, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 07Apr2021, when the patient was 26 years old, for Covid-19 immunization. The following information was reported: PERICARDITIS (medically significant) with onset 14May2021, outcome "recovered", described as "Inflammation around the heart"; DYSPNOEA (non-serious) with onset 14May2021, outcome "recovered", described as "shortness of breath"; CHEST PAIN (non-serious) with onset 14May2021, outcome "recovered", described as "chest pain"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 17Apr2021, outcome "unknown", described as "administration date=17Apr2021, Dose 2/administration date=07Apr2021, Dose 1". The events "inflammation around the heart", "shortness of breath" and "chest pain" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of pericarditis, dyspnoea, chest pain. None of allergies. No other vaccine in four weeks and no other medications in two weeks. No covid prior vaccination and no covid tested post vaccination.
Traveler began Oral typhoid vaccine one day after returning from 4-day business trip  on March 23 2007 in the evening. (Traveler was preparing for subsequent travel) By March 24th evening he had upset stomcah, loose stool (2-3/day)stomach cramps, bloating, and rash on arms that was more intense in the folds of his elbows. The symptoms were improved on the 25th, he took 2nd dose of Vivotif eve of 3/25. Symptoms returned/worsened 3/26.  Traveler called to report the symptoms 3/27.
I woke up with a sore throat and congestion and as the days went by it became progressively worse. I also experienced sneezing, headaches and after Sunday I was so sick I could not get out of bed. I felt like I had zero energy. I felt very lethargic with terrible headaches. I have never felt this way before. I went to the Emergency Room and I tested positive for COVID-19. I tested negative in February and I was negative for antibodies.
5/2/23 I had a sudden pain in my left calf. It did not go away with rest or TYLENOL. I went to the emergency room and had an ultrasound. I was diagnosed with a DVT. I was put on LOVENOX for 5 days and taken off the warfarin. On 5/7/23 I went back to the emergency room because I continued to have symptoms. I had an ultrasound and a CT scan of my chest. The ultrasound showed there was no change in the blood clot. The ultrasound revealed I did not have a pulmonary emboli. After the five days of being on LOVENOX, I was put on PRADAXA.
injection in left delt. Thereafter, left delt pain and weakness, possible parsonage turner syndrome. NO new injury to shoulder, exam with weakness out of proportion to mild OA hx. NO evidence of tendonopathy.
Patient reported having a bug bite like, itchy rash on the underside of the left arm starting a few days after his immunization. A few days later, the same rash appeared on his left leg. He's not sure that it was due to the vaccination, but that was the only thing he could think of that could have caused it. He has never had a reaction to the flu shot in the past.